Novel issues in the combined modality treatment of lymphomas
CLL2-GIVe trial: investigating chemotherapy-free treatment of CLL
Lenalidomide and ibrutinib: do they have a future in treating CLL?
An overview of iwCLL 2017 meeting in New York by Prof. Michael Hallek
HARMONY: a collaboration between 51 partners